300086.SZ
康芝药业
SZSE · Healthcare · C 制造业 · CN
CNY 6.42
−3.02%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−18.5x
Market Cap
CNY 2.92B
MomentumView details →
1D Return
−3.02%
YTD Return
−45.47%
RSI (14)
48.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−18.5x
Market Cap
CNY 2.92B
RSI (14)
48.0
MomentumView details →
1D Return
−3.02%
YTD Return
−45.47%
Similar companies
Latest newsMore news →
Kangzhi Pharmaceutical's controlling shareholder Hongshi Investment pledged 5 million shares to Huaxia Bank Haikou Branch as collateral for working capital loans.2d agoKangzhi Pharmaceutical announced its first-half 2026 results, reporting a net loss of 32.77 million yuan, compared with a loss of 54.08 million yuan in the same period of 2025.10d ago